Onebright, the UK’s largest private outpatient mental healthcare company, significantly expands its neurodevelopmental services with the acquisition of Psicon Ltd for an undisclosed sum.
Onebright provides a comprehensive range of market-leading mental healthcare services, including neurodevelopmental assessments, to its private medical insurance, corporate, and consumer clients. With the addition of Psicon, the mental healthcare company has increased its breadth and depth of capabilities in this important area.
Psicon is a leading and rapidly growing provider of neurodevelopmental assessments for Autism and ADHD, and works extensively with the NHS, as well as providing private assessments to the public. The organisation offers a full range of assessment and treatment services across the lifespan and is one of the largest providers of children’s neurodevelopmental services in the UK.
The two brands will operate independently with Psicon continuing to be led by Managing Director Dr Dan Simmonds. With the support of Onebright it will significantly invest in its operational and technology capabilities and continue its UK expansion to enable more people to benefit from its exceptional services.
The new enlarged group will employ over 500 staff delivering services remotely and from a growing number of face-to-face clinics. Its operational centres are in York, London, and Canterbury.
Commenting on the acquisition Donald Fowler, CEO of Onebright, said: “We are delighted to welcome Psicon to the Onebright family. Our mission at Onebright is to create a brighter tomorrow by providing easy access to personalised, life-changing mental health support, and the addition of Psicon and its team to our group will really enhance our ability to deliver on this mission. From very early on in our discussions it was apparent that our two organisations share a passion for clinical excellence and patient-centred care, and I am really looking forward to what we can achieve together.”
Commenting Dr Dan Simmonds, managing director of Psicon, said: “Demand for high-quality support for the neurodivergent population has increased substantially up and down the country and we look forward to working within the Onebright family to further support NHS Trusts, Integrated Care Boards, and private patients across the UK.”
Commenting LJ Conradie, Psicon founder, retired MD, and Chairman, said: “I am very proud of all the achievements at Psicon over the last 25 years and very excited about the Psicon Onebright union. Passing the baton to leaders with focus on strong values and high-quality services will, without doubt, continue to be the basis of future success.”
